News

Indoco Remedies announced the launch of Fevindo (favipiravir) 400 mg tablets in India. Fevindo - 400 is an antiviral drug, effective against the RNA-based influenza virus. The drug has been approved by DCGI in the treatment of COVID-19. Fevindo 400...

The first batch of Russia’s coronavirus vaccine Sputnik V has entered “civil circulation”, reports from state media claimed on Thursday. The first potential vaccine in the world is now available to public in the capital city of Moscow. Although the...

Italian-based Stevanato Group, a leading producer of pharmaceutical glass containers and provider of integrated capabilities for drug delivery systems, has officially inaugurated its Technology Excellence Center (TEC) in Boston, Massachusetts. The new Center provides a full-service approach to support biopharma...

ChargePoint Technology, specialists in contained and sterile powder transfer solutions, has further strengthened its leadership team with the appointment of Emma Stoddart as Chief Financial Officer. Having been a partner at Grant Thornton where she spent over 20 years of...

Durbin, part of Uniphar Group, has been appointed to design and implement a global Early Access Program (EAP) on behalf of Jazz Pharmaceuticals plc for a new medicine containing the active substance, solriamfetol, and known commercially as Sunosi®. The therapy...

A £1 million crowdfunding campaign launched by PHARMASEAL to revolutionise global clinical trials and vaccine development has reached the next campaign milestone. Launched by the new provider of clinical trial management and governance solutions last month, the campaign is aimed...

Due to the continuous strong demand for disinfectants, specialty chemicals company LANXESS is planning to expand its production capacity for Oxone monopersulfate by around 50 percent. To this end, the company intends to invest a lower double-digit million euro...